BACKGROUND: Human metapneumovirus (hMPV) is a newly discovered paramyxovirus that causes acute respiratory illness. Despite apparent near-universal exposure during early childhood, immunity is transient. METHODS: An indirect screening enzyme-linked immunosorbent assay using a recombinant soluble fusion (F) glycoprotein derived from hMPV was used to test for anti-F IgG in 1,380 pairs of acute- and convalescent-stage serum samples collected from children in Kamphaeng Phet, Thailand. RESULTS: Of the 1,380 serum sample pairs tested, 1,376 (99.7%) showed evidence of prior infection with hMPV. Sixty-six paired specimens demonstrated a >or=4-fold rise in titer, for an overall reinfection rate of 4.9%. Two children demonstrated evidence of an initial infection. Forty-eight of the 68 new infections or reinfections occurred in 2000, accounting for 13.2% of all nonflaviviral febrile illnesses in the study population in that year. Of 68 positive cases, 85.3% complained of cough and 66.2% complained of rhinorrhea, compared with 61.4% and 49.0% of negative cases, respectively (P < .01). All positive samples were also tested for an increase in titer of antibodies to respiratory syncytial virus F, and 27% exhibited a >or=4-fold rise. CONCLUSION: These results demonstrate that hMPV reinfections cause illness at a rate equal to that seen for initial infections. hMPV may have a more significant impact in older children than previously realized and may be the cause of significant outbreaks in this population.
BACKGROUND:Human metapneumovirus (hMPV) is a newly discovered paramyxovirus that causes acute respiratory illness. Despite apparent near-universal exposure during early childhood, immunity is transient. METHODS: An indirect screening enzyme-linked immunosorbent assay using a recombinant soluble fusion (F) glycoprotein derived from hMPV was used to test for anti-F IgG in 1,380 pairs of acute- and convalescent-stage serum samples collected from children in Kamphaeng Phet, Thailand. RESULTS: Of the 1,380 serum sample pairs tested, 1,376 (99.7%) showed evidence of prior infection with hMPV. Sixty-six paired specimens demonstrated a >or=4-fold rise in titer, for an overall reinfection rate of 4.9%. Two children demonstrated evidence of an initial infection. Forty-eight of the 68 new infections or reinfections occurred in 2000, accounting for 13.2% of all nonflaviviral febrile illnesses in the study population in that year. Of 68 positive cases, 85.3% complained of cough and 66.2% complained of rhinorrhea, compared with 61.4% and 49.0% of negative cases, respectively (P < .01). All positive samples were also tested for an increase in titer of antibodies to respiratory syncytial virus F, and 27% exhibited a >or=4-fold rise. CONCLUSION: These results demonstrate that hMPV reinfections cause illness at a rate equal to that seen for initial infections. hMPV may have a more significant impact in older children than previously realized and may be the cause of significant outbreaks in this population.
Authors: Mario H Skiadopoulos; Stéphane Biacchesi; Ursula J Buchholz; Jeffrey M Riggs; Sonja R Surman; Emerito Amaro-Carambot; Josephine M McAuliffe; William R Elkins; Marisa St Claire; Peter L Collins; Brian R Murphy Journal: J Virol Date: 2004-07 Impact factor: 5.103
Authors: Wanida Thanasugarn; Rujipat Samransamruajkit; Pijitra Vanapongtipagorn; Nuanchan Prapphal; Bernadette Van den Hoogen; Albert D M E Osterhaus; Yong Poovorawan Journal: Scand J Infect Dis Date: 2003
Authors: John V Williams; Paul A Harris; Sharon J Tollefson; Lisa L Halburnt-Rush; Joyce M Pingsterhaus; Kathryn M Edwards; Peter F Wright; James E Crowe Journal: N Engl J Med Date: 2004-01-29 Impact factor: 91.245
Authors: Samantha Bosis; Susanna Esposito; Hubert G M Niesters; Piero Crovari; Albert D M E Osterhaus; Nicola Principi Journal: J Med Virol Date: 2005-01 Impact factor: 2.327
Authors: Bernadette G van den Hoogen; Sander Herfst; Leo Sprong; Patricia A Cane; Eduardo Forleo-Neto; Rik L de Swart; Albert D M E Osterhaus; Ron A M Fouchier Journal: Emerg Infect Dis Date: 2004-04 Impact factor: 6.883
Authors: Paul K S Chan; John S Tam; Ching-Wan Lam; Edward Chan; Alan Wu; Chi-Kong Li; Thomas A Buckley; King-Cheung Ng; Gavin M Joynt; Frankie W T Cheng; Ka-Fai To; Nelson Lee; David S C Hui; Jo L K Cheung; Ida Chu; Esther Liu; Sydney S C Chung; Joseph J Y Sung Journal: Emerg Infect Dis Date: 2003-09 Impact factor: 6.883
Authors: John J Erickson; Meredith C Rogers; Andrew K Hastings; Sharon J Tollefson; John V Williams Journal: J Immunol Date: 2014-10-22 Impact factor: 5.422
Authors: Verena Schildgen; Bernadette van den Hoogen; Ron Fouchier; Ralph A Tripp; Rene Alvarez; Catherine Manoha; John Williams; Oliver Schildgen Journal: Clin Microbiol Rev Date: 2011-10 Impact factor: 26.132
Authors: Andrea E González; Margarita K Lay; Evelyn L Jara; Janyra A Espinoza; Roberto S Gómez; Jorge Soto; Claudia A Rivera; Katia Abarca; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis Journal: Virulence Date: 2016-12-02 Impact factor: 5.882
Authors: Andrew K Hastings; John J Erickson; Jennifer E Schuster; Kelli L Boyd; Sharon J Tollefson; Monika Johnson; Pavlo Gilchuk; Sebastian Joyce; John V Williams Journal: J Virol Date: 2015-02-04 Impact factor: 5.103
Authors: John V Williams; Kathryn M Edwards; Geoffrey A Weinberg; Marie R Griffin; Caroline B Hall; Yuwei Zhu; Peter G Szilagyi; Chiaoyin K Wang; Chin-Fen Yang; David Silva; Dan Ye; Richard R Spaete; James E Crowe Journal: J Infect Dis Date: 2010-06-15 Impact factor: 5.226
Authors: John J Erickson; Meredith C Rogers; Sharon J Tollefson; Kelli L Boyd; John V Williams Journal: J Immunol Date: 2016-06-03 Impact factor: 5.422